Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Fung

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
The American Journal of Gastroenterology|March 3, 2011
Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safetyMan-Fung Yuen, Wai-Kay Seto, James Fung, et al.
Journal of Viral Hepatitis|March 15, 2025
Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA DetectionRex Wan-Hin Hui, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
The American Journal of Gastroenterology|August 10, 2011
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatmentJames Fung, Ching-Lung Lai, John Young, et al.
Antiviral Therapy|August 26, 2009
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapyMan-Fung Yuen, James Fung, Wai-Kay Seto, et al.
Vaccine|October 7, 2008
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final reportDavid Yiu-Kuen But, Ching-Lung Lai, Wei-Ling Lim, et al.
Hepatology (Baltimore, Md.)|November 7, 2020
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral TherapyLung-Yi Mak, Gavin Cloherty, Danny Ka-Ho Wong, et al.
Hepatology International|May 14, 2021
Statins associate with better clinical outcomes in chronic hepatitis B patients with HBsAg seroclearanceKa Shing Cheung, Lung Yi Mak, Lok Ka Lam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2017
The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infectionJie Li, Lung-Yi Mak, Danny Ka-Ho Wong, et al.
Progress in Brain Research|July 22, 2019
Eye-hand re-coordination: A pilot investigation of gaze and reach biofeedback in chronic strokeJohn-Ross Rizzo, Mahya Beheshti, Azadeh Shafieesabet, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
The American Journal of Gastroenterology|March 3, 2011
Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safetyMan-Fung Yuen, Wai-Kay Seto, James Fung, et al.
Journal of Viral Hepatitis|March 15, 2025
Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA DetectionRex Wan-Hin Hui, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
The American Journal of Gastroenterology|August 10, 2011
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatmentJames Fung, Ching-Lung Lai, John Young, et al.
Antiviral Therapy|August 26, 2009
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapyMan-Fung Yuen, James Fung, Wai-Kay Seto, et al.
Vaccine|October 7, 2008
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final reportDavid Yiu-Kuen But, Ching-Lung Lai, Wei-Ling Lim, et al.
Hepatology (Baltimore, Md.)|November 7, 2020
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral TherapyLung-Yi Mak, Gavin Cloherty, Danny Ka-Ho Wong, et al.
Hepatology International|May 14, 2021
Statins associate with better clinical outcomes in chronic hepatitis B patients with HBsAg seroclearanceKa Shing Cheung, Lung Yi Mak, Lok Ka Lam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2017
The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infectionJie Li, Lung-Yi Mak, Danny Ka-Ho Wong, et al.
Progress in Brain Research|July 22, 2019
Eye-hand re-coordination: A pilot investigation of gaze and reach biofeedback in chronic strokeJohn-Ross Rizzo, Mahya Beheshti, Azadeh Shafieesabet, et al.
Pageof 20